Molecular Pharmacology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to rapidly publish novel data concerning molecular pharmacology. Pharmacology is a discipline which deals with the interaction of a drug of natural, semisynthetic or fully (bio)synthetic origin with the human or animal organism. Thus, it is positioned at the interface of pharmacy/chemistry and physiology/pathophysiology in their broadest sense. It operates at various organizational levels, such as the molecular, subcellular, cellular, organ, and systemic platforms. Molecular pharmacology investigates the molecular mode of action of drugs, among others using genetic and molecular biology methods, and in consequence, it is one of the most rapidly developing fields of pharmacology. We encourage submission of manuscripts that report significant advances on the molecular level in drug research but especially appreciate submissions which, in addition, follow up on the consequences of molecular changes on higher levels of organization.
Keywords
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Bioactive Compounds and Health 2.0 (Deadline: 10 July 2024)
- Early-Stage Drug Discovery: Advances and Challenges 2.0 (Deadline: 15 July 2024)
- G Protein-Coupled Receptors: Signaling, Regulation and Therapeutic Opportunities (Deadline: 15 July 2024)
- Novel Approaches for Topical or Transdermal Delivery of Large Molecules (Deadline: 15 July 2024)
- Advances in Proteasome Inhibition (Deadline: 15 July 2024)
- Advances in Protein Tyrosine Phosphatases (Deadline: 15 July 2024)
- Topoisomerase Inhibitors: Future Perspectives and Challenges (Deadline: 20 July 2024)
- Insights into Redox Homeostasis and Oxidative Stress (Deadline: 20 July 2024)
- Natural-Derived Bioactive Compounds in Disease Treatment (Deadline: 20 July 2024)
- RNA Vaccines and Therapeutics: Challenges and Opportunities (Deadline: 20 July 2024)
- Advanced Synthetic Methodologies in Drug Development (Deadline: 29 July 2024)
- Novel PET Radiopharmaceuticals: Molecular Probes for Personalized Imaging 2.0 (Deadline: 30 July 2024)
- Synthesis and Biological Evaluation of Pyrazole Derivatives (Deadline: 30 July 2024)
- Molecular Pharmacology of Human Metabolism Diseases (Deadline: 30 July 2024)
- New Types of Antibacterial Biocides 2.0 (Deadline: 30 July 2024)
- Molecular Pharmacology in Diabetes 2.0 (Deadline: 30 July 2024)
- The Future of Drug Discovery and Development, 2nd Edition (Deadline: 30 July 2024)
- Cutting-Edge Research on Antiviral Therapy (Deadline: 30 July 2024)
- Natural Compounds and Strategies for Developing Novel Anti-inflammatory Drugs (Deadline: 30 July 2024)
- Natural Products: Antioxidants and Neuroprotection (Deadline: 30 July 2024)
- Aptamer-Based Tissue-Targeted Drug Delivery (Deadline: 31 July 2024)
- Nutrients and Natural Agents as Drug Leads for Product Development (Deadline: 31 July 2024)
- Anticancer Drug Discovery Based on Natural Products (Deadline: 31 July 2024)
- Advanced Research on Chemokines and Chemokine Receptors (Deadline: 31 July 2024)
- Drug Treatment for Bacterial Infections (Deadline: 31 July 2024)
- Redox Regulation and Drug Discovery (Deadline: 31 July 2024)
- Drug Discovery Based on Natural Products (Deadline: 31 July 2024)
- Advances in Protein-Protein Interactions—2nd Edition (Deadline: 31 July 2024)
- Mitochondrial Medicine: Pharmacological Targeting of Mitochondria in Disease 2.0 (Deadline: 20 August 2024)
- Antiviral Drug Targets: Structure, Function, and Drug Design 2.0 (Deadline: 20 August 2024)
- Stem Cell Technology and Genome Editing in Advanced Disease Modeling (Deadline: 20 August 2024)
- Natural Products and Synthetic Compounds for Drug Development 2.0 (Deadline: 20 August 2024)
- Biomarkers and Drug Targets for Longevity (Deadline: 29 August 2024)
- Antifungal Drug Discovery: Progresses, Challenges, Opportunities (Deadline: 29 August 2024)
- Discovery and Molecular Mechanisms of New Anticancer Drugs (Deadline: 30 August 2024)
- Effect of Cardioprotective Drugs on the Cardiovascular System (Deadline: 30 August 2024)
- Novel Antimicrobial Agents (Deadline: 30 August 2024)
- TRP Channel, 2nd Edition (Deadline: 30 August 2024)
- The Impact of Natural Bioactive Compounds on Human Health and Disease (Deadline: 31 August 2024)
- Latest Advances in Protein-Ligand Interactions (Deadline: 31 August 2024)
- Advances in Polymers and Polysaccharides in Delivery Systems (Deadline: 31 August 2024)
- Biological Variability: A Challenge in Therapeutics and Drug Design (Deadline: 31 August 2024)
- Antimicrobial and Antiviral Peptides (Deadline: 20 September 2024)
- Recent Research on Antimicrobial Agents (Deadline: 20 September 2024)
- Current Advances in Novel Antiviral Drugs (Deadline: 20 September 2024)
- Advances in Classic and Psychedelic Pharma for Psychiatric Diseases (Deadline: 20 September 2024)
- Molecular Mechanisms and Pharmacological Approaches for Brain Injury (Deadline: 20 September 2024)
- Techniques and Strategies in Drug Design and Discovery, 2nd Edition (Deadline: 20 September 2024)
- Coordination Compounds as Diagnostic, Therapeutic and Theranostic Agents (Deadline: 20 September 2024)
- New Insights into Anti-cancer Drug Discovery and Development (Deadline: 20 September 2024)
- Natural Products as Multitarget Agents in Human Diseases (Deadline: 20 September 2024)
- Novel Pharmacology of Diabetic Complications (Deadline: 20 September 2024)
- Precision Medicine for Oral Diseases and Cancers (Deadline: 20 September 2024)
- Pharmacogenomics 3.0 (Deadline: 20 September 2024)
- Emerging Topics in Metal Complexes: Pharmacological Activity, 2nd Edition (Deadline: 25 September 2024)
- Macrophage Polarization and Human Inflammatory Diseases (Deadline: 25 September 2024)
- Anti-obesity Drug Discovery (Deadline: 25 September 2024)
- Molecular Research of Therapeutic Target Enzymes (Deadline: 27 September 2024)
- Hormone/Receptor System in Human Diseases (Deadline: 30 September 2024)
- Revealing New Molecular Mechanisms in Medicinal Chemistry (Deadline: 30 September 2024)
- Role of Natural Products in Health and Diseases (Deadline: 30 September 2024)
- Selected Papers for the 30th International Conference on Chelation (ICOC)—a Landmark on Metal Chelation Science and Medicine (Deadline: 30 September 2024)
- Molecular Pharmacology of Cardiovascular Disease, 2nd Edition (Deadline: 30 September 2024)
- Latest Review Papers in Molecular Pharmacology 2024 (Deadline: 30 September 2024)
- Molecular Research on Antibody–Drug Conjugates (Deadline: 30 September 2024)
- Nutrients, Natural Products and Nanoparticles for the Development of New Therapeutic Agents (Deadline: 30 September 2024)
- New Drugs Regulating Cytoskeletons in Human Health and Diseases (Deadline: 30 September 2024)
- Application of Natural Products in Biomedicine and Pharmacotherapy: 2nd Edition (Deadline: 30 September 2024)
- Recent Advances of Novel Pharmaceutical Designs for Anti-cancer Therapies, 3rd Edition (Deadline: 15 October 2024)
- Current Research in Pharmacognosy: A Focus on Biological Activities (Deadline: 20 October 2024)
- Natural Bioactive Compounds for Human Health 2.0 (Deadline: 20 October 2024)
- Molecular Mechanisms and Therapeutic Approaches to Osteoarthritis (Deadline: 20 October 2024)
- Antiviral Activity of Lectins (Deadline: 20 October 2024)
- Advances in Anti-inflammatory Drug Development (Deadline: 20 October 2024)
- Medical Value of Metal Complexes and Plant-Derived Compounds: Biological Evaluation, Health Effects, Challenges, and Future Opportunities (Deadline: 25 October 2024)
- Anticancer Antibiotics: Progresses, Opportunities and Challenges (Deadline: 30 October 2024)
- Pharmacological Treatment of Neuropsychiatric Disorders (Deadline: 30 October 2024)
- Molecular Advances on Cannabinoid and Endocannabinoid Research 2.0 (Deadline: 31 October 2024)
- Discovering Novel Bioactive Compounds against Cancers (Deadline: 31 October 2024)
- Structure–Activity Relationships within Pharmaceutical Interactions and the Discovery of Molecular Targets (Deadline: 31 October 2024)
- Molecular Mechanisms of Herbal Compounds in Neuroprotection (Deadline: 10 November 2024)
- New Agents and Novel Drugs Use for the Oncological Diseases Treatment (Deadline: 15 November 2024)
- Recent Approaches for Wound Treatment—2nd Edition (Deadline: 20 November 2024)
- Recent Progress of Opioid Research 2.0 (Deadline: 20 November 2024)
- Molecular Pharmacology of Antidepressants (Deadline: 20 November 2024)
- Synthesis and Molecular Research of Drugs for Skin Diseases and Cosmetic Ingredients (Deadline: 30 November 2024)
- Synthetic and Natural Drugs for Pain Treatment (Deadline: 30 November 2024)
- Antituberculous Drugs: Progress and Challenges (Deadline: 30 November 2024)
- The Role of Bioactive Compounds in Human Health and Disease 2.0 (Deadline: 30 November 2024)
- Drug Repurposing in Rare Diseases: From Molecular Insights to Patient Benefits (Deadline: 30 November 2024)
- Molecular Pharmacology and Metabolic Signaling in Health and Disease (Deadline: 30 November 2024)
- Biomedical Applications of Mesenchymal Stem Cells (Deadline: 30 November 2024)
- Drug Resistance and Biomarkers in Molecular Oncology (Deadline: 30 November 2024)
- Bioactive Peptides: Synthesis, Functions, and Medicinal Chemistry Applications (Deadline: 30 November 2024)
- Phytochemicals for Diabetes: Natural Plant-Based Therapies (Deadline: 30 November 2024)
- Molecular Pharmacology of Medicinal Plants (Deadline: 30 November 2024)
- Synthesis and Application of Chiral Ligands and Heterocycles in Pharmacological Studies (Deadline: 30 November 2024)
- Endocannabinoid Receptors in Human Health and Disease, 2nd Edition (Deadline: 10 December 2024)
- Advances in Drug Delivery Systems: From Nanoparticles to Precision Medicine (Deadline: 15 December 2024)
- Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers 3.0 (Deadline: 15 December 2024)
- Advanced Research on N-chlorotaurine and Other Active Halogen Taurine Derivatives (Deadline: 20 December 2024)
- Drug Resistance in Cancer: Molecular Mechanisms and Tackling Strategies 2.0 (Deadline: 20 December 2024)
- Advanced Research on the Adrenal Gland and Hormones (Deadline: 20 December 2024)
- Flow Cytometry for Safety Assessment in Drug Discovery (Deadline: 20 December 2024)
- Gene-Level Pharmacological Research on Natural Products (Deadline: 20 December 2024)
- Biorhythm-Based Drug Design and Development (Deadline: 20 December 2024)
- Plant-Derived Natural Substances as Multi-target Therapeutic Modalities in Experimental Models of Non-communicable Diseases (Deadline: 20 December 2024)
- Biocatalysis of Compounds for Pharmaceutical and Biomedical Applications (Deadline: 30 December 2024)
- Research on Drug Metabolism and Disposition (Deadline: 31 December 2024)
- Antiviral Drugs Discovery (Deadline: 31 December 2024)
- Epilepsy Research and Antiepileptic Drugs 2.0 (Deadline: 20 January 2025)
- Editorial Board Members’ Collection Series: Pain (Deadline: 20 January 2025)
- Drug Discovery: Design, Synthesis and Activity Evaluation (Deadline: 31 January 2025)
- Advances in Drug Discovery and Synthesis: 2nd Edition (Deadline: 31 January 2025)
Topical Collections
Following topical collections within this section are currently open for submissions: